US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

ACER

Acer Therapeutics (ACER)

Acer Therapeutics Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACER

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
08/11/2023	15:13	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:ACER	Acer Therapeutics Inc
08/11/2023	15:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACER	Acer Therapeutics Inc
02/11/2023	07:51	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ACER	Acer Therapeutics Inc
02/11/2023	07:30	GlobeNewswire Inc.	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals	NASDAQ:ACER	Acer Therapeutics Inc
10/10/2023	16:17	Edgar (US Regulatory)	Form DEFM14A - Definitive proxy statement relating to merger or acquisition	NASDAQ:ACER	Acer Therapeutics Inc
31/08/2023	06:30	GlobeNewswire Inc.	Zevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Product	NASDAQ:ACER	Acer Therapeutics Inc
30/08/2023	15:05	GlobeNewswire Inc.	Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe	NASDAQ:ACER	Acer Therapeutics Inc
14/08/2023	15:19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACER	Acer Therapeutics Inc
14/08/2023	15:05	GlobeNewswire Inc.	Acer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:ACER	Acer Therapeutics Inc
26/06/2023	08:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACER	Acer Therapeutics Inc
26/06/2023	07:30	GlobeNewswire Inc.	Acer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder	NASDAQ:ACER	Acer Therapeutics Inc
15/05/2023	16:29	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ACER	Acer Therapeutics Inc
15/05/2023	16:10	GlobeNewswire Inc.	Acer Therapeutics Reports Q1 2023 Financial Results and Provides Corporate Update	NASDAQ:ACER	Acer Therapeutics Inc
01/05/2023	07:30	GlobeNewswire Inc.	Acer Therapeutics Announces OLPRUVA™ Commercial Launch Progressing Ahead of Schedule	NASDAQ:ACER	Acer Therapeutics Inc
27/04/2023	05:25	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NASDAQ:ACER	Acer Therapeutics Inc
14/04/2023	15:29	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:ACER	Acer Therapeutics Inc
27/03/2023	15:18	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ACER	Acer Therapeutics Inc
27/03/2023	15:13	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ACER	Acer Therapeutics Inc
27/03/2023	15:01	GlobeNewswire Inc.	Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update	NASDAQ:ACER	Acer Therapeutics Inc
23/03/2023	15:17	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ACER	Acer Therapeutics Inc
22/03/2023	07:30	GlobeNewswire Inc.	Acer Therapeutics Announces Data Presented at Society for Inherited Metabolic Disorders Annual Meeting Identifying Preferred Urea Cycle Disorder Treatment Attributes	NASDAQ:ACER	Acer Therapeutics Inc
22/03/2023	07:00	GlobeNewswire Inc.	Acer Therapeutics Announces $2.675 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:ACER	Acer Therapeutics Inc
17/03/2023	07:30	GlobeNewswire Inc.	Acer Therapeutics Announces Topline Results from ACER-801 (Osanetant) Phase 2a Trial	NASDAQ:ACER	Acer Therapeutics Inc
16/03/2023	15:51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACER	Acer Therapeutics Inc
15/03/2023	07:30	GlobeNewswire Inc.	Acer Therapeutics Announces Presentation of HCP Urea Cycle Disorder Treatment Preference Data at the Society for Inherited Metabolic Disorders Annual Meeting and Provides OLPRUVA™ Program Update	NASDAQ:ACER	Acer Therapeutics Inc
14/02/2023	16:17	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ACER	Acer Therapeutics Inc
13/02/2023	07:30	GlobeNewswire Inc.	Acer Therapeutics Announces Full Enrollment of Phase 2a Trial of ACER-801 (Osanetant) for Treatment of Moderate to Severe Vasomotor Symptoms Associated with Menopause	NASDAQ:ACER	Acer Therapeutics Inc
31/01/2023	07:00	PR Newswire (US)	SWK Holdings Provides Portfolio Update Highlighting Recent Achievements	NASDAQ:ACER	Acer Therapeutics Inc
09/01/2023	07:30	GlobeNewswire Inc.	Acer Therapeutics Highlights Key 2022 Achievements and Pipeline Advancements, and Provides Anticipated 2023 Milestones	NASDAQ:ACER	Acer Therapeutics Inc
05/01/2023	07:30	GlobeNewswire Inc.	Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate	NASDAQ:ACER	Acer Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:ACER

1 2 3 Próxima >

Deutsche Telekom (QX)

American Express

BNP Paribas (QX)

Verizon Communications

Gold vs US Dollar

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones